178 related articles for article (PubMed ID: 33232319)
1. LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1.
Luo P; Wu S; Ji K; Yuan X; Li H; Chen J; Tian Y; Qiu Y; Zhong X
PLoS One; 2020; 15(11):e0223035. PubMed ID: 33232319
[TBL] [Abstract][Full Text] [Related]
2. Long-chain Non-coding RNA MIR4435-2HG Expression Correlates With Size of Intestinal Polyps in Children and With Metastasis of Colon Cancer.
Zhu D; Guo P; Jin XY; Zhang R; Ji G; Yang Z; Hoffman RM; Sheng W
Anticancer Res; 2022 Oct; 42(10):4707-4714. PubMed ID: 36191994
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MIR4435-2HG recruits miR-802 from FLOT2 to promote melanoma progression.
Ma DM; Sun D; Wang J; Jin DH; Li Y; Han YE
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2616-2624. PubMed ID: 32196611
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.
Pei L; Yan D; He Q; Kong J; Yang M; Ruan H; Lin Q; Huang L; Huang J; Lin T; Qin H
Cell Oncol (Dordr); 2023 Oct; 46(5):1509-1527. PubMed ID: 37355516
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MIR4435-2HG-mediated upregulation of TGF-β1 promotes migration and proliferation of nonsmall cell lung cancer cells.
Yang M; He X; Huang X; Wang J; He Y; Wei L
Environ Toxicol; 2020 May; 35(5):582-590. PubMed ID: 31875359
[TBL] [Abstract][Full Text] [Related]
6. The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling.
Qian H; Chen L; Huang J; Wang X; Ma S; Cui F; Luo L; Ling L; Luo K; Zheng G
J Mol Med (Berl); 2018 Aug; 96(8):753-764. PubMed ID: 29872866
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MIR4435-2HG contributes into colorectal cancer development and predicts poor prognosis.
Shen MY; Zhou GR; -Y Zhang Z
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1771-1777. PubMed ID: 32141545
[TBL] [Abstract][Full Text] [Related]
8. MIR4435-2HG, miR-125b-5p, and Sema4D axis affects the aggressiveness of colorectal cancer cells.
Yu M; Yi Z; Chen S; Chen X; Xie X
Folia Histochem Cytobiol; 2022; 60(2):191-202. PubMed ID: 35730423
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2'-O methylation.
Zhu Y; Xiao B; Liu M; Chen M; Xia N; Guo H; Huang J; Liu Z; Wang F
Cell Mol Biol Lett; 2023 Oct; 28(1):89. PubMed ID: 37891494
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis.
Xiao Y; Bao Y; Tang L; Wang L
J Orthop Surg Res; 2019 Aug; 14(1):247. PubMed ID: 31387631
[TBL] [Abstract][Full Text] [Related]
11. lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression.
Yang T; Li Y; Wang G; Guo L; Sun F; Li S; Deng X; Liu J
Biomed Res Int; 2022; 2022():3858249. PubMed ID: 35993042
[TBL] [Abstract][Full Text] [Related]
12. MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis.
Zhong C; Xie Z; Zeng LH; Yuan C; Duan S
Front Immunol; 2022; 13():855078. PubMed ID: 35784328
[TBL] [Abstract][Full Text] [Related]
13. MIR4435-2HG: A newly proposed lncRNA in human cancer.
Zhang M; Yu X; Zhang Q; Sun Z; He Y; Guo W
Biomed Pharmacother; 2022 Jun; 150():112971. PubMed ID: 35447550
[TBL] [Abstract][Full Text] [Related]
14. MIR4435-2HG regulates cancer cell behaviors in oral squamous cell carcinoma cell growth by upregulating TGF-β1.
Shen H; Sun B; Yang Y; Cai X; Bi L; Deng L; Zhang L
Odontology; 2020 Oct; 108(4):553-559. PubMed ID: 32016787
[TBL] [Abstract][Full Text] [Related]
15. M2 Macrophage-Derived Exosomal lncRNA MIR4435-2HG Promotes Progression of Infantile Hemangiomas by Targeting HNRNPA1.
Li Z; Cao Z; Li N; Wang L; Fu C; Huo R; Xu G; Tian C; Bi J
Int J Nanomedicine; 2023; 18():5943-5960. PubMed ID: 37881607
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression By Reprogramming Neutrophils.
Yu H; Chen C; Han F; Tang J; Deng M; Niu Y; Lai M; Zhang H
Cancer Immunol Res; 2022 Sep; 10(9):1095-1110. PubMed ID: 35862232
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis.
Zhu L; Wang A; Gao M; Duan X; Li Z
Cancer Cell Int; 2020; 20():145. PubMed ID: 32377170
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.
Ke J; Wang Q; Zhang W; Ni S; Mei H
Am J Transl Res; 2022; 14(8):5441-5454. PubMed ID: 36105009
[TBL] [Abstract][Full Text] [Related]
19. LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway.
Shi W; Ling L; Li C; Wu R; Zhang M; Shao F; Wang Y
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1295-1311. PubMed ID: 35792913
[TBL] [Abstract][Full Text] [Related]
20. MIR4435-2HG: A Tumor-associated Long Non-coding RNA.
Zhao F; Liu Y; Tan F; Tang L; Du Z; Mou J; Zhou G; Yuan C
Curr Pharm Des; 2022; 28(25):2043-2051. PubMed ID: 35674305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]